Russian Registry of Surgical OutcomeS
RuSOS
National Register of Postoperative Outcomes in the Russian Federation: a Multicenter Observational Study
1 other identifier
observational
162,000
1 country
16
Brief Summary
Identification of risk factors that cause a high probability of an unfavorable outcome in the postoperative period is an urgent problem. The creation of national databases (registries) makes it possible to maximally cover a certain patient population by identifying its characteristic risk predictors. As literature data show, existing registries differ in the criteria for inclusion in the study, in the characteristics of the populations studied, and there is often no common view on the classification of postoperative outcomes. Goal of a study is a creation of a Russian national calculator for the risk of postoperative complications and mortality. Two-level observational retrospective-prospective study was planned. Setting: National multicenter study of surgical inpatients. Patients: Adult patients undergoing elective and emergency surgery. Types of interventions: in obstetrics, in gynecology, on the breast, in urology and kidneys, in endocrine surgery, in maxillofacial surgery, in orthopedics and traumatology, on the lower floor of the abdominal cavity, on the liver and biliary tract, on the upper floor of the abdominal cavity cavities, in thoracic surgery, in vascular surgery, in neurosurgery, in cardiac surgery, in other areas (with mandatory specification). The study was organized by the Federation of Anesthesiologists and Reanimatologists of Russia. Primary (30-day mortality, 30-day complications) and secondary (hospital mortality, hospital complications, length of stay in anesthesiology, resuscitation and intensive care departments, length of hospital stay, multiple organ failure (2 or more points on the SOFA scale (Sequential)) Organ Failure Assessment), 90-day mortality, 90-day complications, intensive care after-effects syndrome, readmission, 1-year mortality) outcomes were determined. The required sample size and statistical analysis methods are described. The planned duration of the study is 2024-2028.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2025
Longer than P75 for all trials
16 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 18, 2023
CompletedFirst Posted
Study publicly available on registry
November 24, 2023
CompletedStudy Start
First participant enrolled
January 9, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2029
April 4, 2025
April 1, 2025
4 years
November 18, 2023
April 1, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Postoperative mortality
Incidence of postoperative death defined as any death occurring during and up to 30 days after surgery
up to 30 days after surgery
Postoperative complications
Incidence of the following complications with severity due to Clavien-Dindo classification: Arrhythmia Cardiac arrest Cardiogenic pulmonary edema Deep vein thrombosis Myocardial infarction Myocardial damage after non-cardiac operations Pulmonary embolism Postoperative transfusion Postoperative delirium Stroke ARDS Acute respiratory failure Pneumonia Pleural effusion Atelectasis Respiratory infection Bronchospasm Pneumothorax Aspiration pneumonitis Reintubation Renal injury Infection without a specific source Laboratory confirmed bacteremia Superficial wound infection Deep wound infection Postoperative infection Urinary tract infection Sepsis Septic shock Gastrointestinal bleeding Paralytic ileus Postoperative bleeding Anastomotic leakage Dehiscence of wound Other Malignant hyperthermia Anaphylaxis Anaphylactic shock Fat embolism
up to 30 days after surgery
Secondary Outcomes (8)
Length of stay in the ICU
up to 30 days after surgery
Length of hospital stay
up to 30 days after surgery
Multiple organ failure (2 or more points on the SOFA (Sequential Organ Failure Assessment) scale)
up to 30 days after surgery
90-days mortality
up to 90 days after surgery
90-days postoperative complications
up to 90 days after surgery
- +3 more secondary outcomes
Study Arms (2)
Cohort A
A cohort in which the incidence of the primary outcomes in the study population will be assessed.
Cohort B
A cohort in which risk factors for primary outcomes will be identified, and a risk calculator for their development will be developed and validated
Eligibility Criteria
Adult patients undergoing surgery in various areas of surgery
You may qualify if:
- Adult patients (age 18 years and older) undergoing elective surgery:
- In obstetrics
- In gynecology
- Breast
- In urology and kidneys
- In endocrine surgery
- In maxillofacial surgery
- In orthopedics and traumatology
- On the lower abdominal cavity
- On the liver and biliary tract
- On the upper abdominal cavity
- In thoracic surgery
- In vascular surgery
- In neurosurgery
- In cardiac surgery
- +2 more criteria
You may not qualify if:
- Lack of informed consent from the patient
- Complications associated with the manipulations of an anesthesiologist
- Interventions without the participation of an anesthesiologist-resuscitator
- Incomplete checklists
- Errors when filling checklists
- Deviations from the Register protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (16)
The First City Clinical Hospital. n.a. E. E. Volosevich
Arkhangelsk, Russia
Kuzbass Clinical Emergency Hospital named after M.A. Podgorbunsky
Kemerovo, Russia
Regional clinical hospital №2
Krasnodar, 350012, Russia
Kuban State Medical University
Krasnodar, 350063, Russia
Krasnodar regional hospital №2 (Kuban State Medical University)
Krasnodar, Russia
Regional clinical hospital
Krasnoyarsk, Russia
Federal research and clinical center of intensive care medicine and rehabilitology
Moscow, Russia
Loginov Moscow Clinical Scientific Center
Moscow, Russia
Military Medical Academy
Moscow, Russia
Moscow cancer research Institute named after P. A. Herzen
Moscow, Russia
Moscow Regional Research and Clinical Institute, Moscow, Russia
Moscow, Russia
Moscow regional research clinical Institute named after M. F. Vladimirsky
Moscow, Russia
Orenburg City N.I. Pirogov Clinical Hospital
Orenburg, Russia
North-Western State Medical University named after Ilya I. Mechnikov,
Saint Petersburg, Russia
Regional clinical hospital №2
Vladivostok, Russia
Clinical city hospital № 40
Yekaterinburg, Russia
Study Officials
- STUDY CHAIR
Igor Zabolotskikh, MD
Kuban State Medical University
- STUDY DIRECTOR
Nikita Trembach, MD
Kuban State Medical University
- STUDY DIRECTOR
Andrey Belkin, MD
Clinical Institute of Brain
- STUDY DIRECTOR
Evgeniy Grigiriev, MD
Research Institute for Complex Issues of Cardiovascular Diseases
- STUDY DIRECTOR
Alexei Gritsan, MD
Voino-Yasenetsky Krasnoyarsk State Medical University
- STUDY DIRECTOR
Pavel Dunts, PhD
Pacific State Medical University
- STUDY DIRECTOR
Vadim Ershov, MD
Orenburg State Medical University
- STUDY DIRECTOR
Mikhail Kirov, MD
Northern State Medical University
- STUDY DIRECTOR
Artem Kuzovlev, MD
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology
- STUDY DIRECTOR
Alexandr Kulikov, MD
Ural State Medical University
- STUDY DIRECTOR
Alexey Ovezov, MD
Moscow Regional Research and Clinical Institute
- STUDY DIRECTOR
Denis Protsenko, MD
Pirogov Russian National Research Medical University
- STUDY DIRECTOR
Valeriy Subbotin, MD
Loginov Moscow Clinical Scientific Center
- STUDY DIRECTOR
Victoria Khoronenko, MD
P. A. Hertsen Moscow Oncology Research Center
- STUDY DIRECTOR
Efim Shifman, MD
Moscow Regional Research and Clinical Institute, Moscow, Russia
- STUDY DIRECTOR
Alexey Shchegolev, MD
Military Medical Academy, Bulgaria
- STUDY DIRECTOR
Konstantin Lebedinskii, MD
North-Western State Medical University named after Ilya I. Mechnikov
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 18, 2023
First Posted
November 24, 2023
Study Start
January 9, 2025
Primary Completion (Estimated)
December 31, 2028
Study Completion (Estimated)
January 31, 2029
Last Updated
April 4, 2025
Record last verified: 2025-04